Article Versions Notes

Dumas P-Y, Bertoli S, Bérard E, Largeaud L, Bidet A, Delabesse E, Leguay T, Leroy H, Gadaud N, Rieu JB, et al. Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study. Cancers. 2020; 12(8):2044. https://doi.org/10.3390/cancers12082044

Dumas, Pierre-Yves, Sarah Bertoli, Emilie Bérard, Laetitia Largeaud, Audrey Bidet, Eric Delabesse, Thibaut Leguay, Harmony Leroy, Noémie Gadaud, Jean Baptiste Rieu, and et al. 2020. "Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study" Cancers 12, no. 8: 2044. https://doi.org/10.3390/cancers12082044

Dumas, P.-Y., Bertoli, S., Bérard, E., Largeaud, L., Bidet, A., Delabesse, E., Leguay, T., Leroy, H., Gadaud, N., Rieu, J. B., Vial, J.-P., Vergez, F., Lechevalier, N., Luquet, I., Klein, E., Sarry, A., de Grande, A.-C., Pigneux, A., & Récher, C. (2020). Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study. Cancers, 12(8), 2044. https://doi.org/10.3390/cancers12082044